Cullinan Therapeutics Cancer Drug Shows Efficacy In Brain Metastases Among Lung Cancer Patients With Certain Mutations

Why is Warner Bros. Discovery up for sale? How did OpenAI’s new browser impact Google stock? Why is Beyond Meat stock surging recently? What caused Netflix’s earnings miss this quarter? How will Japan’s new PM affect its economy? Why is Amazon replacing thousands of workers with robots? What’s behind the recent drop in gold prices?

Cullinan Therapeutics Cancer Drug Shows Efficacy In Brain Metastases Among Lung Cancer Patients With Certain Mutations

benzinga.com/news/health-care/25/10/48181455/cullinan-therapeutics-cancer-drug-shows-efficacy-in-brain-metastases-among-lung-cancer-patients-

Taiho Oncology Inc. and Cullinan Therapeutics Inc. (NASDAQ:CGEM) shared new data on Sunday from the central nervous system (CNS) involvement cohort of the REZILIENT2 study of zipalertinib for advanced or metastatic non-small cell lung cancer (NSCLC) harboring EGFR exon 20 insertion…

This story appeared on benzinga.com, 2025-10-13 16:46:34.